Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Amphotericin B Lipid Complex for invasive cryptococcosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Cryptococcosis

Drugs mentioned

• Amphotericin B lipid complex (amphotericin B lipid complex)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Invasive Cryptococcosis | Phase 4 | Status: WITHDRAWN